Lighthouse Investment Partners’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
VCM
VPM
EIG
Lighthouse Investment Partners's DGX Position: Q1 2026 in Review
Lighthouse Investment Partners sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 2,407 shares — an estimated $418K sold.
Lighthouse Investment Partners first reported a position in DGX in Q3 2023 and held it in 5 quarters. The position peaked at $7.34M in Q1 2024. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Lighthouse Investment Partners reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
- Lighthouse Investment Partners sold 2,407 Quest Diagnostics shares in Q1 2026, an estimated $418K.
- Lighthouse Investment Partners first reported a position in Quest Diagnostics in Q3 2023 and held it in 5 quarters.
- Lighthouse Investment Partners's Quest Diagnostics position peaked at $7.34M in Q1 2024.
- 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.